Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

Thanks for the input and I may be down to one question (though somehow I doubt it).

"The only way the FDA would get involved in off-label use is if the use of the drug for an indication other than that for which it were approved, proved dangerous. Hard to imagine that would be the case, here."

Probably so. Does it matter that in this case the drug would be prescribed in anticipation of a disease that might be contracted and not to treat an existing disease?
I guess I'm startled by what seems to be total freedom on the part of a doctor to prescribe an approved drug for ANYTHING that they feel might be an appropriate use. I know you folks are smart, but you're human, too. Sounds as if the FDA, other than as regards safety issues that might reveal themselves in off-label uses (when it's too late), turns the ball entirely over to you in terms of efficacy decisions once a drug is approved. Do I have that right?